Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENDOXAN BAXTER for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where ENDOXAN BAXTER was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for ENDOXAN BAXTER

Side Effect Reports % Deaths Hosp.
Death 29 22.5% 29 0
Non-hodgkin's lymphoma 12 9.3% 12 1
Disease progression 11 8.5% 0 0
Exposure during pregnancy 11 8.5% 0 0
Chronic graft versus host disease 10 7.8% 0 0
Foetal exposure during pregnancy 8 6.2% 0 0
No adverse event 8 6.2% 0 0
Recurrent cancer 8 6.2% 0 0
Plasma cell myeloma 5 3.9% 0 0
Primary mediastinal large b-cell lymphoma recurrent 5 3.9% 0 0

Other Indications for ENDOXAN BAXTER

Stem cell transplant (27) Hodgkin's disease (17) B-cell lymphoma (14) Bone marrow conditioning regimen (11) Multiple sclerosis (11) Foetal exposure timing unspecified (8) Plasma cell myeloma (8) Breast cancer (7) Non-hodgkin's lymphoma (7) Primary mediastinal large b-cell lymphoma (5)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

ENDOXAN BAXTER Full Profile All Diffuse large b-cell lymphoma Drugs ENDOXAN BAXTER Demographics ENDOXAN BAXTER Timeline